Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model One out of the three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading down 9 points (-0.1%) at 12,786 as of Tuesday, Nov. 20, 2012, 11:49 AM ET. The NYSE advances/declines ratio sits at 1,471 issues advancing vs. 1,424 declining with 128 unchanged. The Industrial Goods sector currently sits up 0.5% versus the S&P 500, which is up 0.0%. Top gainers within the sector include Masco Corporation ( MAS), up 4.3%, CNH Global ( CNH), up 2.5%, Toll Brothers ( TOL), up 2.4%, Mohawk Industries ( MHK), up 1.9% and Eaton ( ETN), up 0.9%. On the negative front, top decliners within the sector include Parker Hannifin Corporation ( PH), down 1.9%, Nidec Corporation ( NJ), down 1.7% and General Dynamics ( GD), down 0.7%. TheStreet Ratings group would like to highlight 5 stocks pushing the sector higher today: 5. DR Horton ( DHI) is one of the companies pushing the Industrial Goods sector higher today. As of noon trading, DR Horton is up $0.48 (2.5%) to $19.50 on average volume Thus far, 3.2 million shares of DR Horton exchanged hands as compared to its average daily volume of 6.6 million shares. The stock has ranged in price between $19.19-$19.51 after having opened the day at $19.35 as compared to the previous trading day's close of $19.02. D.R. Horton, Inc. operates as a homebuilding company in the United States. The company's Homebuilding segment engages in the acquisition and development of land, and construction and sale of residential homes in 25 states and 73 markets in the United States primarily under the D.R. DR Horton has a market cap of $6.0 billion and is part of the materials & construction industry. The company has a P/E ratio of 6.3, below the S&P 500 P/E ratio of 17.7. Shares are up 49.9% year to date as of the close of trading on Monday. Currently there are 5 analysts that rate DR Horton a buy, 3 analysts rate it a sell, and 7 rate it a hold. TheStreet Ratings rates DR Horton as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, compelling growth in net income, notable return on equity and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full DR Horton Ratings Report now.